Metoprolol Tartrate
64 NDCs across 11 manufacturers|63 Generic,1 Brand
Metoprolol Tartrate is used to treat angina pectoris, atrial fibrillation, atrial flutter, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Dec 21, 1993. FDA's Orange Book lists 30 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $107 million on Metoprolol Tartrate across 15.9 million claims for 3.9 million beneficiaries.
Metoprolol Tartrate is available as 64 NDCs from 11 manufacturers (63 generic, 1 brand), with NADAC prices from $0.02 to $2.42 per EA — the most expensive product costs about 152× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
64
63G / 1B
Manufacturers
11
competing in market
Price Spread
$0.02 – $2.42
per EA
7d Activity
avg +2.6% WoW · of 64 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Advagen Pharma Ltd. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
beta-Adrenergic Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing METOPROLOL TARTRATE(1 pricing outlier)
Frequently Asked Questions
What is Metoprolol Tartrate used to treat?
Metoprolol Tartrate is used to treat angina pectoris, atrial fibrillation, atrial flutter, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
When did Metoprolol Tartrate become available as a generic?
FDA approved the first generic Metoprolol Tartrate (ANDA) on Dec 21, 1993. The Orange Book currently lists 30 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Metoprolol Tartrate?
In 2024, Medicare Part D spent $107 million on Metoprolol Tartrate across 15.9 million claims for 3.9 million beneficiaries.
How many Metoprolol Tartrate products are on the market?
The Metoprolol Tartrate drug market contains 64 NDCs from 11 manufacturers — 63 generic and 1 brand product.
What is the price range for Metoprolol Tartrate?
NADAC reference prices for Metoprolol Tartrate range from $0.0159 to $2.4163 per EA — the most expensive product costs about 152× the cheapest.
Is generic Metoprolol Tartrate cheaper than brand?
The average generic NADAC for Metoprolol Tartrate is $0.0300 per EA, versus $2.4163 for brand-labeled products — brand versions average about 81× the generic price.
Which manufacturers make Metoprolol Tartrate?
11 manufacturers list Metoprolol Tartrate in NADAC. Ranked by number of NDCs, the largest are Advagen Pharma Ltd. (18), TruPharma LLC (14), Mylan Pharmaceuticals Inc. (8), Rising Pharma Holdings Inc. (6), Aurobindo Pharma Limited (6).
How has the price of Metoprolol Tartrate changed recently?
Over the past 7 days, 37 Metoprolol Tartrate NDCs rose and 22 fell, with a market-wide average change of +2.6%.